Eligibility depends on health history
[DOI] [PubMed] [Google Scholar] Berlin 1978 Berlin R, Berlin H, Brante G, Pilbrant A
It is believed that hydroxocobalamin is converted to active enzyme more easily and retained in the body for a longer period of time than cyanocobalamin, and therefore be administered in intervals of 3 months
Additionally, research suggests that semaglutide may also reduce A1C levels in people with or without diabetes, making it a dual-purpose treatment [5]
Oral Administration (if applicable): For oral formulations of AOD-9604 , research has shown bioavailability of approximately 40% in animal studies
Avoid sodium azide when it may interfere with downstream applications, especially cell-based assays